Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...

Oxford Brain Diagnostics (OBD), a pioneer in quantitative brain biology, today announced new research demonstrating that its ...

WELTRUZA ™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous ...

AbCellera (Nasdaq: ABCL) today announced an upcoming poster presentation of Phase 1/2 data on ABCL635 at The Menopause ...

Guardant360 CDx can now help identify cancer mutations earlier and drive improved patient outcomes in major global ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Formation Bio today announced that Anirvan Ghosh, PhD, has joined the company as SVP, Head of Translational Sciences. Ghosh ...

Ginkgo Bioworks (NYSE: DNA) today announced that it will provide in-kind access to its autonomous laboratory in Boston to ...

Dean Merder to serve as Executive Advisor to the Chairman, following eight years of leadership. WASHINGTON, Ind.--(BUSINESS ...

Tevogen is also actively considering other transactions with a focus on life sciences and healthcare-related businesses; ...

NHS Blood and Transplant's Therapeutic Apheresis Services (TAS) and Cellular and Molecular Therapies (CMT) teams are ...

TORONTO, Oct. 8, 2026 /CNW/ -- Apotex Health Corp. ("Apotex") (TSX: APTX) today announced that it will issue a press release ...